Wissenschaftliche Arbeiten

Uzm. Dr. Mustafa Serkan Alemdar

25 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey

    Current Oncology, 2026

    DOI 10.3390/curroncol33040216 PMID 42041735 Frei zugänglicher VolltextQuelle: ORCID

  2. Causal Impact of Hemoglobin Levels on Global Quality of Life in Patients with Cancer

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15041579 PMID 41753266 Frei zugänglicher VolltextQuelle: ORCID

  3. Extent of Resection and Survival in IDH-Wildtype Glioblastoma: A Dual-Center Retrospective Study

    Medicina, 2026

    DOI 10.3390/medicina62020385 PMID 41752783 Frei zugänglicher VolltextQuelle: ORCID

  4. Real-world outcomes of trifluridine/tipiracil with or without bevacizumab in refractory metastatic colorectal cancer: a multicenter cohort study from Turkey

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-05158-y PMID 42104040 Frei zugänglicher VolltextQuelle: OpenAlex

  5. Analysing Emotional Well-Being in Cancer Patients: A Natural Language Processing Approach to Correlating Text with Hospital Anxiety and Depression Scale Scores

    Current Oncology, 2026

    DOI 10.3390/curroncol33070400 PMID 42505202 Frei zugänglicher VolltextQuelle: OpenAlex

  6. The Use of Artificial Intelligence Chatbots by Newly Diagnosed Cancer Patients: A Descriptive Phenomenological Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33090563 PMID 42782909 Frei zugänglicher VolltextQuelle: OpenAlex

  7. Association of neoadjuvant treatment-initiation season with pathological response and survival in locally advanced rectal cancer

    Journal of Health Sciences and Medicine, 2026

    DOI 10.32322/jhsm.1991234 Frei zugänglicher VolltextQuelle: OpenAlex

  8. The prognostic value of the Systemic Immune-Inflammation Index at diagnosis in small cell lung cancer

    Journal of Medicine and Palliative Care, 2026

    DOI 10.47582/jompac.1996340 Frei zugänglicher VolltextQuelle: OpenAlex

  9. Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach

    Cancers, 2025

    DOI 10.3390/cancers17020233 PMID 39858018 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  10. Predictive value of tumor marker index for pathological complete response following neoadjuvant chemoradiotherapy in locally advanced rectal cancer

    World Journal of Surgical Oncology, 2025

    DOI 10.1186/s12957-025-04081-w PMID 41327416 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  11. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy

    Medical Science Monitor, 2024

    DOI 10.12659/msm.943750 PMID 38544312 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  12. Sarcopenia’s Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis

    Medical Science Monitor, 2024

    DOI 10.12659/msm.945240 PMID 39587458 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  13. Single Apheresis Session on the 4th Day of Granulocyte Colony-Stimulating Factor Administration Seems Convenient to Collect Enough Peripheral Blood Stem Cells from Healthy Donors

    Transfusion Medicine and Hemotherapy, 2024

    DOI 10.1159/000538457 PMID 39664457 Frei zugänglicher VolltextQuelle: ORCID

  14. Solving the puzzle of quality of life in cancer: integrating causal inference and machine learning for data-driven insights

    Health and Quality of Life Outcomes, 2024

    DOI 10.1186/s12955-024-02274-7 PMID 39113111 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  15. 1271P Integrating machine learning prediction and causal inference analysis to unravel determinants of progression in EGFR-mutant, advanced NSCLC

    Annals of Oncology, 2024

    DOI 10.1016/j.annonc.2024.08.1328 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  16. Lower Body Mass Index and Prognostic Nutritional Index Are Associated with Poor Posttransplant Outcomes in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

    Oncology (Switzerland), 2023

    DOI 10.1159/000531576 PMID 37364535 6 Zitationen (Europe PMC) Quelle: ORCID

  17. Temel Onkoloji

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1765 Quelle: OpenAlex

  18. Onkolojide İmmünoterapi

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1749 Quelle: OpenAlex

  19. Tacrolimus-Associated Pure Red Cell Aplasia in a Patient With Renal Transplant

    Experimental and Clinical Transplantation, 2022

    DOI 10.6002/ect.2020.0290 PMID 33272158 3 Zitationen (Europe PMC) Quelle: ORCID

  20. Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia

    Chemotherapy, 2021

    DOI 10.1159/000512314 PMID 33316797 1 Zitation (Europe PMC) Quelle: ORCID

  21. Erişkin Ailevi Akdeniz Ateşi Hastalarında Ataksız Dönemdeki Serum Amiloid A’nın Diğer İnflamatuar Belirteçlerle Korelasyonu

    OSMANGAZİ JOURNAL OF MEDICINE, 2021

    DOI 10.20515/otd.938690 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  22. Does Location of the Tumor Affect Prognosis, Survival, and Relapse in Patients With Stage 3 Colorectal Cancers?

    Akdeniz Medical Journal, 2021

    DOI 10.17954/amj.2021.2672 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  23. Impact of Antibiotics and Corticosteroids on The Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma

    Akdeniz Medical Journal, 2021

    DOI 10.17954/amj.2021.2570 Frei zugänglicher VolltextQuelle: OpenAlex

  24. Matrix regenerating agent (RGTA) plays a prominent role in treating persistent epithelial defects

    Journal of EuCornea, 2020

    DOI 10.1016/j.xjec.2020.03.001 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  25. The prognostic significance of neutrophil/lymphocyte ratio in patients with terminal cancer

    Hematology Transfusion and Cell Therapy, 2020

    DOI 10.1016/j.htct.2020.09.061 Frei zugänglicher VolltextQuelle: OpenAlex